Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (3)

Search Parameters:
Keywords = South Asian diabetes dataset

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
13 pages, 640 KiB  
Article
Investigating the Role of GDF-15 in Diabetes and Obesity: A Comprehensive Analysis of a Cohort from the KDEP Study
by Jehad Abubaker, Mohamed Abu-Farha, Ahmed N. Albatineh, Irina Al-Khairi, Preethi Cherian, Hamad Ali, Ibrahim Taher, Fahad Alajmi, Mohammed Qaddoumi, Muhammad Abdul-Ghani and Fahd Al-Mulla
Biomedicines 2025, 13(7), 1589; https://doi.org/10.3390/biomedicines13071589 - 30 Jun 2025
Viewed by 467
Abstract
Background: Growth differentiation factor 15 (GDF-15), a member of the transforming growth factor-β (TGF-β) superfamily, is upregulated under cellular stress conditions and has emerged as a potential biomarker for metabolic disorders. However, its expression in relation to diabetes and obesity across different demographic [...] Read more.
Background: Growth differentiation factor 15 (GDF-15), a member of the transforming growth factor-β (TGF-β) superfamily, is upregulated under cellular stress conditions and has emerged as a potential biomarker for metabolic disorders. However, its expression in relation to diabetes and obesity across different demographic groups remains understudied. This study investigated the association between plasma GDF-15 levels, diabetes mellitus, and obesity in individuals of varying ages, ethnicities, and genders. Methods: In a cross-sectional study, plasma GDF-15 concentrations were measured in 2083 participants enrolled in the Kuwait Diabetes Epidemiology Program (KDEP). The dataset included anthropometric, clinical, biochemical, and glycemic markers. Multivariate regression analysis was used to examine associations between GDF-15 levels and metabolic phenotypes. Results: Mean plasma GDF-15 levels were significantly higher in males than females (580.6 vs. 519.3 ng/L, p < 0.001), and in participants >50 years compared to those <50 years (781.4 vs. 563.4 ng/L, p < 0.001). Arab participants had higher GDF-15 levels than South and Southeast Asians (597.0 vs. 514.9 and 509.9 ng/L, respectively; p < 0.001). Positive correlations were found with BMI, waist and hip circumferences, blood pressure, insulin, and triglycerides; negative correlations were observed with HDL cholesterol. Median regression indicated that elevated GDF-15 levels were independently and significantly associated with male gender, older age, obesity, diabetes, and insulin resistance. Adjusted median regression indicated that male gender (β = 30.1, 95%CI: 11.7, 48.5), older age (β = 9.4, 95%CI: 8.0, 10.7), and insulin resistance (β = 7.73, 95%CI: 1.47, 14.0) indicated a significant positive association with GDF-15. South Asian participants (β= −41.7, 95%CI: −67.2, −16.2) had significantly but Southeast Asian participants (β= −23.3, 95%CI: −49.2, 2.56) had marginally significantly lower GDF-15 levels compared to participants of Arab ethnicity. Conclusions: Higher GDF-15 levels are associated with age, male gender, Arab ethnicity, obesity, and diabetic traits. These findings support the potential role of GDF-15 as a biomarker for metabolic disorders, particularly in high-risk demographic subgroups. Full article
Show Figures

Figure 1

9 pages, 237 KiB  
Article
Factors Associated with Mortality in Coronavirus-Associated Mucormycosis: Results from Mycotic Infections in COVID-19 (MUNCO) Online Registry
by Shitij Arora, Shivakumar Narayanan, Melissa Fazzari, Kranti Bhavana, Bhartendu Bharti, Shweta Walia, Neetu Kori, Sushila Kataria, Pooja Sharma, Kavya Atluri, Charuta Mandke, Vinod Gite, Neelam Redkar, Mayank Chansoria, Sumit Kumar Rawat, Rajani S. Bhat, Ameet Dravid, Yatin Sethi, Chandan Barnawal, Nirmal Kanti Sarkar, Sunit Jariwala, William Southern and Yoram Puiusadd Show full author list remove Hide full author list
J. Clin. Med. 2022, 11(23), 7015; https://doi.org/10.3390/jcm11237015 - 27 Nov 2022
Cited by 3 | Viewed by 2828
Abstract
Background: COVID-19-associated mucormycosis (CAM) is associated with high morbidity and mortality. MUNCO is an international database used to collect clinical data on cases of CAM in real time. Preliminary data from the Mycotic Infections in COVID-19 (MUNCO) online registry yielded 728 cases from [...] Read more.
Background: COVID-19-associated mucormycosis (CAM) is associated with high morbidity and mortality. MUNCO is an international database used to collect clinical data on cases of CAM in real time. Preliminary data from the Mycotic Infections in COVID-19 (MUNCO) online registry yielded 728 cases from May to September 2021 in four South Asian countries and the United States. A majority of the cases (694; 97.6%) consisted of a mucormycosis infection. The dataset allowed for the analysis of the risk factors for adverse outcomes from CAM and this analysis is presented in this paper. Methods: The submission of cases was aided by a direct solicitation and social media online. The primary endpoints were full recovery or death measured on day 42 of the diagnosis. All patients had histopathologically confirmed CAM. The groups were compared to determine the contribution of each patient characteristic to the outcome. Multivariable logistic regression models were used to model the probability of death after a CAM diagnosis. Results: The registry captured 694 cases of CAM. Within this, 341 could be analyzed as the study excluded patients with an unknown CAM recovery status due to either an interruption or a lack of follow up. The 341 viable cases consisted of 258 patients who survived after the completion of treatment and 83 patients who died during the period of observation. In a multivariable logistic regression model, the factors associated with an increased risk of mortality include old age (OR = 1.04, 95% CI 1.02–1.07, p = 0.001), history of diabetes mellitus (OR 3.5, 95% CI 1.01–11.9, p = 0.02) and a lower BMI (OR 0.9, 95% CI 0.82–0.98, p = 0.03). Mucor localized to sinus disease was associated with 77% reduced odds of death (OR = 0.23, 95% CI 0.09–0.57, p = 0.001), while cerebral mucor was associated with an increased odds of death (OR = 10.96, 95% CI 4.93–24.36, p = ≤0.0001). Conclusion: In patients with CAM, older age, a history of diabetes and a lower body mass index is associated with increased mortality. Disease limited to the sinuses without a cerebral extension is associated with a lower risk of mortality. Interestingly, the use of zinc and azithromycin were not associated with increased mortality in our study. Full article
(This article belongs to the Special Issue COVID-19: Clinical Advances and Challenges)
25 pages, 738 KiB  
Article
Early Prediction of Diabetes Using an Ensemble of Machine Learning Models
by Aishwariya Dutta, Md. Kamrul Hasan, Mohiuddin Ahmad, Md. Abdul Awal, Md. Akhtarul Islam, Mehedi Masud and Hossam Meshref
Int. J. Environ. Res. Public Health 2022, 19(19), 12378; https://doi.org/10.3390/ijerph191912378 - 28 Sep 2022
Cited by 100 | Viewed by 8661
Abstract
Diabetes is one of the most rapidly spreading diseases in the world, resulting in an array of significant complications, including cardiovascular disease, kidney failure, diabetic retinopathy, and neuropathy, among others, which contribute to an increase in morbidity and mortality rate. If diabetes is [...] Read more.
Diabetes is one of the most rapidly spreading diseases in the world, resulting in an array of significant complications, including cardiovascular disease, kidney failure, diabetic retinopathy, and neuropathy, among others, which contribute to an increase in morbidity and mortality rate. If diabetes is diagnosed at an early stage, its severity and underlying risk factors can be significantly reduced. However, there is a shortage of labeled data and the occurrence of outliers or data missingness in clinical datasets that are reliable and effective for diabetes prediction, making it a challenging endeavor. Therefore, we introduce a newly labeled diabetes dataset from a South Asian nation (Bangladesh). In addition, we suggest an automated classification pipeline that includes a weighted ensemble of machine learning (ML) classifiers: Naive Bayes (NB), Random Forest (RF), Decision Tree (DT), XGBoost (XGB), and LightGBM (LGB). Grid search hyperparameter optimization is employed to tune the critical hyperparameters of these ML models. Furthermore, missing value imputation, feature selection, and K-fold cross-validation are included in the framework design. A statistical analysis of variance (ANOVA) test reveals that the performance of diabetes prediction significantly improves when the proposed weighted ensemble (DT + RF + XGB + LGB) is executed with the introduced preprocessing, with the highest accuracy of 0.735 and an area under the ROC curve (AUC) of 0.832. In conjunction with the suggested ensemble model, our statistical imputation and RF-based feature selection techniques produced the best results for early diabetes prediction. Moreover, the presented new dataset will contribute to developing and implementing robust ML models for diabetes prediction utilizing population-level data. Full article
(This article belongs to the Special Issue Applications of Artificial Intelligence to Health)
Show Figures

Figure 1

Back to TopTop